Serious side effects are less common, but its important to be aware of them: Pancreatitis: In rare cases, acute pancreatitis (inflammation of the pancreas) has been reported with GLP-1 agonists like semaglutide
However, retatrutide may have superior benefits for insulin resistance and glycemic regulation , due to: Enhanced insulin sensitivity from GIP agonism Reduced hepatic glucose output from glucagon signaling modulation Improved beta-cell function Clinical Insight: Retatrutide reduced fasting glucose and A1C levels with similar or better efficacy than tirzepatide in early trials
Ponsford MJ, Shillitoe BMJ, Humphreys IR, Gennery AR, Jolles S
A total of 14,154 patients with HFpEF were included after 1:1 propensity score matching
Mice were fasted for 4 h in the morning and killed by conscious decapitation